Market Closed

OCGN
Ocugen
$ 0.8278
-5.24%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Ocugen News

Latest Ocugen Stock News & OCGN Headlines

Ocugen Eyes 2027 Trial Results and FDA Filing for Lead Gene Therapy
3 days ago | marketbeat.com
Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN
5 days ago | globenewswire.com
Ocugen's Q3 Earnings Match Estimates, Revenues Beat, Stock Rises
10 days ago | zacks.com
Ocugen, Inc. (OCGN) Q3 2026 Earnings Call Transcript
10 days ago | seekingalpha.com
Ocugen Q3 Earnings Call Highlights
11 days ago | marketbeat.com
Ocugen (OCGN) Reports Q3 Loss, Tops Revenue Estimates
11 days ago | zacks.com
Ocugen Provides Business Update with Third Quarter 2026 Financial Results
11 days ago | globenewswire.com
Ocugen to Participate in Upcoming November Investor and Industry Conferences
17 days ago | globenewswire.com
Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
24 days ago | globenewswire.com
Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
a month ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

OCGN
Ocugen
$ 0.8278
-5.24%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago